Showing results (191-200 of 226) with videos related to
Sort By:
Pageof 23
Arthritis Care & Research|June 12, 2013
Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registryS Godot, J-E Gottenberg, S Paternotte, et al.Clinical Pharmacokinetics|December 7, 2000
Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cellsF Lapicque, P Vergne, J Y Jouzeau, et al.Annals of the Rheumatic Diseases|September 17, 2008
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyB Combe, C Codreanu, U Fiocco, et al.Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisR Knevel, M Schoels, T W J Huizinga, et al.Annals of the Rheumatic Diseases|July 5, 2005
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of RheumatologyX Le Loët, J M Berthelot, A Cantagrel, et al.Arthritis and Rheumatism|May 28, 2010
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registryJ-E Gottenberg, P Ravaud, T Bardin, et al.Annals of the Rheumatic Diseases|May 22, 2010
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))P Emery, A Deodhar, W F Rigby, et al.Annals of the Rheumatic Diseases|January 7, 2006
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)B Combe, R Landewe, C Lukas, et al.The Journal of Nutrition, Health & Aging|February 5, 2015
Therapeutic management in ambulatory elderly patients with atrial fibrillation: the S.AGES cohortO Hanon, J S Vidal, G Pisica-Donose, et al.The Journal of Rheumatology|August 26, 1998
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritisD Wendling, E Racadot, J Wijdenes, et al.Pageof 23